Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Erasmus University Medical Center currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, indicating a focused prosecution effort. The application is being reviewed within 1 distinct art unit, which suggests the subject matter falls into a specific regulatory category. This concentration of resources allows for a dedicated approach to the patent office's requirements.
The busiest examiner for this portfolio is OYEYEMI, OLAYINKA A, who is responsible for 1 pending office action. As there is 1 distinct examiner involved, this individual is the point of contact for the entity's current dealings with the office. The outcome for this Biotechnology & Pharmaceuticals filing is therefore dependent on the interaction with OYEYEMI, OLAYINKA A. Understanding the specific preferences of this individual is vital for success.
With only 1 distinct art unit involved, the medical center faces a concentrated prosecution path. Practitioners should closely monitor the tendencies of OYEYEMI, OLAYINKA A to navigate the active case effectively. The focus on the 1 pending office action implies that the technical arguments will be the primary factor in the final result for the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OYEYEMI, OLAYINKA A | 1 | 60.4% | +46.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17611545 | NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER | OYEYEMI, OLAYINKA A | 117d overdue |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17611545 | NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER | OYEYEMI, OLAYINKA A | 1681 | §112 | Non-Final OA | 117d overdue | Pending | Nov 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialErasmus University Medical Center has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Olayinka A Oyeyemi has the most, with 1 of Erasmus University Medical Center's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.